The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,329 records6 sources
Showing 529–552 of 11,329
TrialPsilocybin

The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.

ClinicalTrials.gov2026
ArticlePsilocybin

AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression.

Flavin B, Small G, Dragovich C +4

Europe PMC2026
ArticlePsychedelics

843. Not all who wander are lost – Might psychedelics alleviate neurodegeneration and depression in dementia?

Europe PMC2026
ArticlePsychedelics

452. Primary neuronal cultures to study neuroplastic effects of hallucinogen drugs

Europe PMC2026
ArticlePsychedelics

Psychedelics Trials and Outcomes- A Closer Look.

Nayak SM, Weiss B, Yaden DB

Europe PMC2026
ArticlePsychedelics

From Schedule I to the Clinic-Insights Into Psychedelic Drug Development From GHB.

Barnett BS, King F 4th

Europe PMC2026
ArticlePsychedelics

New mouse models for psychedelic studies.

Le Bras A

Europe PMC2026
ArticlePsychedelics

Lilly spends US$2.8 billion on psychedelic drugs for mental health.

Mullard A

Europe PMC2026
ArticlePsychedelics

410. Comparative neurophysiological signatures of psychedelics, stimulants and anesthetics in rodent cortical activity

Europe PMC2026
ArticlePsychedelics

Psychedelics Trials and Outcomes-A Closer Look.

Carhart-Harris RL, Rosenblat JD

Europe PMC2026
ArticlePsychedelics

The Timing of Plasticity: Beyond Synapses in Psychedelic Therapeutics.

Christoffel DJ, Walsh JJ

Europe PMC2026
ArticlePsychedelics

Psychedelics Trials and Outcomes-A Closer Look-Reply.

Szigeti B, Williams ZJ

Europe PMC2026
ArticleKetamine

The mPFC-reuniens-hippocampus pathway links brain circuitry and neural plasticity in antidepressant response.

Veleanu M, Schuberth L, Kilias A +23

Europe PMC2026
ArticlePsychedelics

FDA's New Framework for Psychedelic Drugs.

Davis M, Farchione TR, Fischer BA +1

Europe PMC2026
ArticlePsychedelics

477. Antidepressant action of short-acting psychedelics

Europe PMC2026
ArticlePsychedelics

846. Inconsistent trial risk-of-bias judgements across psychedelic-assisted psychotherapy systematic reviews

Europe PMC2026
ArticlePsychedelics

Development of Japanese Versions of the 4-Item Mystical Experience Questionnaire and 7-Item Challenging Experience Questionnaire.

Umemura F, Kotajima-Murakami H, Strickland JC +3

Europe PMC2026
ArticlePsilocybin

Mycotoxins in Basidiomycete Mycelium and Fruiting Bodies: Implications for Eu Novel Food Assessment and Selected International Regulatory Frameworks.

Berglund NEW, Lankinen PV, Mikkonen KS

Europe PMC2026
DatasetKetamine

Effects of two different intraoperative fluid rates on tissue oxygenation and haemodynamic stability in anaesthetised horses

Raiane Moura, David Freeman, Amber Bisiau +4

Dryad2026
ArticleKetamine

Parvalbumin interneurons under stress: converging mechanisms of vulnerability.

Santos-Silva T, Godoy LD, Guimarães FS +1

Europe PMC2026
TrialKetamine

Brain Activity and Changes in Consciousness During General Anesthesia

ClinicalTrials.gov2026
ArticleMDMA

High Awareness, Low Clarity: Knowledge of the Australian Capital Territory's Multi-Drug Decriminalisation Reform Among People Who Use Illicit Drugs.

Sutherland R, Graham C, Hughes CE +4

Europe PMC2026
Trial

Comparison Between Opioid-Free Anaesthesia Versus Opioid Based Anesthesia in Reduction Postoperative Nausea and Vomiting (PONV)After Thoracoscopic Lung Resection.

ClinicalTrials.gov2026
Trial

Impact of Sedation Practices on Clinical Outcomes Among Mechanically Ventilated Children

ClinicalTrials.gov2026